WEST PHARMACEUTICAL SERVICES INC (WST)

↓ Download CSV

CIK 0000105770 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated PA
  • Fiscal year ends Dec 31

In fiscal 2025, WEST PHARMACEUTICAL SERVICES INC reported revenue of $3.07B, up 6.3% from the prior year. The company was profitable, with a net margin of 16.1% and a gross margin of 35.9%. It held $4.27B in total assets against $1.09B in total liabilities.

Key ratios (FY2025)

35.9%
Gross margin
19.0%
Operating margin
16.1%
Net margin
15.5%
Return on equity
+6.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$3.07B$2.89B$2.95B$2.89B$2.83B$2.15B$1.84B$1.72B
Cost of Revenue$1.97B$1.89B$1.82B$1.75B$1.66B$1.38B$1.23B$1.17B$1.09B$1.01B
Gross Profit$1.10B$998.50M$1.13B$1.14B$1.18B$767.80M$605.70M$545.40M$512.90M$501.40M
Operating Income$584.90M$569.90M$676.00M$734.00M$752.30M$406.90M$296.60M$240.30M$225.80M$195.20M
Net Income$493.70M$492.70M$593.40M$585.90M$661.80M$346.20M$241.70M$206.90M
EPS (Diluted)$6.79$6.69$7.88$7.73$8.67$4.57$3.21$2.74$1.99$1.91
Total Assets$4.27B$3.64B$3.83B$3.62B$3.31B$2.79B$2.34B$1.98B$1.86B$1.72B
Total Liabilities$1.09B$961.10M$948.50M$931.90M$978.40M$939.30M$768.20M$582.60M$582.90M$599.20M
Shareholders' Equity$3.18B$2.68B$2.88B$2.68B$2.34B$1.85B$1.57B$1.40B$1.28B
Cash & Equivalents$791.30M$484.60M$853.90M$894.30M$762.60M$615.50M$439.10M$337.40M$235.90M$203.00M
Operating Cash Flow$754.80M$653.40M$776.50M$724.00M$584.00M$472.50M$367.20M$288.60M$263.30M$219.40M
Capital Expenditures$285.90M$377.00M$362.00M$284.60M$253.40M$174.40M$126.40M$104.70M$130.80M$170.20M
Shares Outstanding72.70M73.70M75.30M75.80M76.30M75.80M75.40M75.40M75.80M75.00M
Dividends Per Share$0.86$0.82$0.78$0.74$0.70$0.66$0.62$0.58$0.54$0.50